Issue 22, 2011

Synthesis and biological activity of optimized belactosin C congeners

Abstract

Successful biochemical studies of the natural products belactosin A and C as well as their more stable acylated derivatives have proved them to be powerful proteasome inhibitors and thereby potential candidates as pharmacologically relevant active compounds. In order to understand their structure–biological activity relations in detail and to find ways of improving their biological activity, four new modified belactosin congeners have been synthesized and tested. One of them (compound 6) turned out to be a more potent inhibitor against HeLa cells than the known proteasome inhibitor MG132.

Graphical abstract: Synthesis and biological activity of optimized belactosin C congeners

Supplementary files

Article information

Article type
Paper
Submitted
27 Apr 2011
Accepted
11 Aug 2011
First published
23 Sep 2011

Org. Biomol. Chem., 2011,9, 7791-7798

Synthesis and biological activity of optimized belactosin C congeners

V. S. Korotkov, A. Ludwig, O. V. Larionov, A. V. Lygin, M. Groll and A. de Meijere, Org. Biomol. Chem., 2011, 9, 7791 DOI: 10.1039/C1OB05661A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements